STATE STREET CORP - TSCAN THERAPEUTICS INC ownership

TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 29 filers reported holding TSCAN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of TSCAN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$106,752
+10.9%
41,700
+8.3%
0.00%
Q2 2023$96,250
+91.0%
38,500
+60.4%
0.00%
Q1 2023$50,400
+15.4%
24,000
-10.4%
0.00%
Q4 2022$43,684
+6.5%
26,800
+100.0%
0.00%
Q3 2022$41,000
-2.4%
13,4000.0%0.00%
Q2 2022$42,000
+20.0%
13,400
+6.3%
0.00%
Q1 2022$35,000
-36.4%
12,600
+3.3%
0.00%
Q4 2021$55,000
-46.1%
12,2000.0%0.00%
Q3 2021$102,00012,2000.00%
Other shareholders
TSCAN THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
DC Funds, LP 630,000$1,323,00030.82%
Deer Management Co. LLC 1,245,505$2,615,5610.24%
Simplify Asset Management Inc. 546,916$1,148,5240.16%
Alphabet Inc. 1,077,080$2,261,8680.12%
Newtyn Management, LLC 236,800$497,2800.10%
DC Investments Management, LLC 35,563$74,6820.09%
Privium Fund Management (UK) Ltd 15,825$40,9870.03%
Baker Brothers Advisors 2,784,792$5,848,0630.03%
Tekla Capital Management LLC 200,000$420,0000.02%
NewEdge Wealth, LLC 91,463$192,0720.01%
View complete list of TSCAN THERAPEUTICS INC shareholders